Found: 37
Select item for more details and to access through your institution.
Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized <sup>13</sup>C magnetic resonance spectroscopy study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 357, doi. 10.1111/dom.13536
- By:
- Publication type:
- Article
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 321, doi. 10.1111/dom.13607
- By:
- Publication type:
- Article
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin‐controlled LDL cholesterol.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 366, doi. 10.1111/dom.13537
- By:
- Publication type:
- Article
Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugs.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 439, doi. 10.1111/dom.13535
- By:
- Publication type:
- Article
Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 349, doi. 10.1111/dom.13534
- By:
- Publication type:
- Article
Acute renal outcomes with sodium‐glucose co‐transporter‐2 inhibitors: Real‐world data analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 340, doi. 10.1111/dom.13532
- By:
- Publication type:
- Article
Comparative risk of genital infections associated with sodium‐glucose co‐transporter‐2 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 434, doi. 10.1111/dom.13531
- By:
- Publication type:
- Article
Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 330, doi. 10.1111/dom.13529
- By:
- Publication type:
- Article
Should sodium‐glucose co‐transporter‐2 inhibitors be considered as first‐line oral therapy for people with type 2 diabetes?
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 207, doi. 10.1111/dom.13518
- By:
- Publication type:
- Article
Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population‐based, propensity‐score‐matched cohort study
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 312, doi. 10.1111/dom.13525
- By:
- Publication type:
- Article
Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 285, doi. 10.1111/dom.13520
- By:
- Publication type:
- Article
Efficacy of intermittent empagliflozin supplementation on dietary self‐management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24‐week randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 303, doi. 10.1111/dom.13524
- By:
- Publication type:
- Article
Comprehensive analysis of body composition and insulin traits associated with intra‐pancreatic fat deposition in healthy individuals and people with new‐onset prediabetes/diabetes after acute pancreatitis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 417, doi. 10.1111/dom.13523
- By:
- Publication type:
- Article
The association of basal insulin treatment versus standard care with outcomes in anti‐GAD positive and negative subjects: A post‐hoc analysis of the ORIGIN trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 429, doi. 10.1111/dom.13528
- By:
- Publication type:
- Article
Intranasal oxytocin fails to acutely improve glucose metabolism in obese men.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 424, doi. 10.1111/dom.13527
- By:
- Publication type:
- Article
Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 408, doi. 10.1111/dom.13517
- By:
- Publication type:
- Article
Metformin is the key factor in elevated plasma growth differentiation factor‐15 levels in type 2 diabetes: A nested, case–control study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 412, doi. 10.1111/dom.13519
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 293, doi. 10.1111/dom.13522
- By:
- Publication type:
- Article
Acute metabolic and cardiovascular effects of mirabegron in healthy individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 276, doi. 10.1111/dom.13516
- By:
- Publication type:
- Article
Comment on: "Glucagon‐like peptide‐1 receptor expression in the human eye".
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
A post‐hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in individuals with type 2 diabetes on a basal‐only insulin regimen.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 402, doi. 10.1111/dom.13515
- By:
- Publication type:
- Article
Changes in arginine are inversely associated with type 2 diabetes: A case‐cohort study in the PREDIMED trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 397, doi. 10.1111/dom.13514
- By:
- Publication type:
- Article
Association of abdominal muscle composition with prediabetes and diabetes: The CARDIA study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 267, doi. 10.1111/dom.13513
- By:
- Publication type:
- Article
Remission in diabetic foot infections: Duration of antibiotic therapy and other possible associated factors.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 244, doi. 10.1111/dom.13507
- By:
- Publication type:
- Article
Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti‐diabetic therapies.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 210, doi. 10.1111/dom.13512
- By:
- Publication type:
- Article
Real‐world opportunity of empagliflozin to improve blood pressure control in African American patients with type 2 diabetes: A National Cardiovascular Data Registry "research‐to‐practice" project from the diabetes collaborative registry.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 393, doi. 10.1111/dom.13510
- By:
- Publication type:
- Article
Comment on "Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D)"
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 252, doi. 10.1111/dom.13508
- By:
- Publication type:
- Article
Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 261, doi. 10.1111/dom.13511
- By:
- Publication type:
- Article
Efficacy and safety of once‐weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52‐week open‐label, randomized phase III trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 234, doi. 10.1111/dom.13506
- By:
- Publication type:
- Article
Mechanistic insights from sequential combination therapy with a sodium glucose co‐transporter‐2 inhibitor and a dipeptidyl peptidase‐4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptin.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 388, doi. 10.1111/dom.13505
- By:
- Publication type:
- Article
Genetic polymorphisms of the endocannabinoid system in obesity and diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 382, doi. 10.1111/dom.13504
- By:
- Publication type:
- Article
The impact of food order on postprandial glycaemic excursions in prediabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 377, doi. 10.1111/dom.13503
- By:
- Publication type:
- Article
Comparison of healthcare resource utilization and costs in patients with type 2 diabetes initiating dapagliflozin versus sitagliptin.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 227, doi. 10.1111/dom.13502
- By:
- Publication type:
- Article
Brain glucose uptake is associated with endogenous glucose production in obese patients before and after bariatric surgery and predicts metabolic outcome at follow‐up.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 218, doi. 10.1111/dom.13501
- By:
- Publication type:
- Article
The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 372, doi. 10.1111/dom.13500
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 205, doi. 10.1111/dom.13426
- Publication type:
- Article